Pharma & Bio
Business·Industry
PinoBio Smiles as Celltrion’s Clinical Trials Progress Smoothly… Aims for Three New Technology Transfers This Year
PinoBio, a developer of antibody-drug conjugates (ADCs), is aiming to secure up to three new technology transfer deals by the end of the year. This is because PinoBio is currently engaged in meaningfu…
Business·Industry
'ADC All-Rounder' Kanap Therapeutics: A Top Performer in the Technology Transfer Relay
Kanap Therapeutics, a newcomer that listed on KOSDAQ in March of this year, possesses the capability to independently develop all components of antibody-drug conjugates. Kanap Therapeutics is attracti…
Technology
Yang Gil-an, CEO of CoaStem ChemOn: “U.S. Regenerative Medicine Institution Proposed Collaboration First… Accelerating Expansion into the U.S.”
“We didn’t knock on the U.S. door. U.S. regenerative medicine research institutions approached us first.”Yang Gil-an, CEO of #CoastemChemOn, recently spoke with PharmEdaily—Edaily’s premium pharmaceut…
Lifestyle
GI Innovation and Orient Bio Surge on Strong Data and Governance [K-Bio Pulse]
While foreign and institutional capital continues to be heavily concentrated in the semiconductor sector of the South Korean stock market, the biotechnology segment successfully held its ground on Jun…
Lifestyle
Amid Continued Concentration in Semiconductors, G.I. Innovation and Orient Bio Show Performance and Accountability, Shares Rise [Bio Spotlight]
Amid a persistent trend of foreign and institutional investors heavily concentrating their funds in the semiconductor sector in the domestic stock market recently, the biotech sector managed to hold i…
Technology
Shin Seong-seop, Executive Vice President of KSBL: “We Will Compete in the Global Market for Nano-Anticancer Drugs by Integrating Technology, Production, and Sales Networks”
“KSBL aims to compete in the global market by integrating technology, production, and sales networks, particularly in the field of complex generics—which are difficult to manufacture—and specifically …
Technology
Will the 20-Year Quest for a Domestic Foot-and-Mouth Disease Vaccine Finally Be Fulfilled? OptiPharm Enters Final Stage
The domestic livestock industry is on the verge of achieving the localization of foot-and-mouth disease (FMD) vaccines, a product it has relied on imports for decades. With #OptiPharm recently receivi…
Technology
CoreLineSoft Goes Beyond Simple Image Analysis, Opening a Blue Ocean in 'Digital Biomarkers'
#CoreLineSoft is reaching a turning point where it will expand beyond simple image interpretation assistance into the digital biomarker business. This is because CoreLineSoft has secured AI-based quan…
Lifestyle
"From Diagnosis to Treatment"... FutureChem: What Is the Strategy to Complete the Puzzle with Therapeutic Radiopharmaceuticals?
#FutureChem has decided on a final round of fundraising ahead of its full-scale revenue generation and has secured a cash cow, allowing it to accelerate the development of FC705, a radiopharmaceutical…
Technology
Curocell’s ‘Limkato,’ the First Domestically Developed CAR-T Therapy, Sets Sights on Japan
#Curocell, the first Korean company to successfully commercialize the chimeric antigen receptor T-cell (CAR-T) therapy Limkato, is now setting its sights on the Japanese market as its next strategic t…